Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Other Non-Current Assets: 2014-2025

Historic Other Non-Current Assets for Viridian Therapeutics, Inc.\DE (VRDN) over the last 11 years, with Sep 2025 value amounting to $1.5 million.

  • Viridian Therapeutics, Inc.\DE's Other Non-Current Assets rose 77.96% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 77.96%. This contributed to the annual value of $501,000 for FY2024, which is 17.05% down from last year.
  • As of Q3 2025, Viridian Therapeutics, Inc.\DE's Other Non-Current Assets stood at $1.5 million, which was up 200.00% from $506,000 recorded in Q2 2025.
  • In the past 5 years, Viridian Therapeutics, Inc.\DE's Other Non-Current Assets ranged from a high of $1.5 million in Q1 2022 and a low of $1,000 during Q1 2021.
  • Over the past 3 years, Viridian Therapeutics, Inc.\DE's median Other Non-Current Assets value was $659,000 (recorded in 2024), while the average stood at $828,545.
  • Per our database at Business Quant, Viridian Therapeutics, Inc.\DE's Other Non-Current Assets surged by 154,100.00% in 2022 and then plummeted by 44.34% in 2024.
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's Other Non-Current Assets (Quarterly) stood at $1.5 million in 2021, then tumbled by 34.14% to $982,000 in 2022, then plummeted by 38.49% to $604,000 in 2023, then declined by 17.05% to $501,000 in 2024, then surged by 77.96% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q3 2025, $506,000 for Q2 2025, and $489,000 during Q1 2025.